The Food & Drug Administration has awarded a three-year, $1.5 million grant to the ADA Science & Research Institute (ADASRI) and the University of Pittsburgh to develop a clinical practice guideline for managing acute pain in dentistry with a focus on the role of opioids.
“The ADA has long been committed to providing the best possible information about managing acute pain for patients, including focusing on further defining the role of opioids in dentistry,” said Marcelo Araujo, DDS, MS, PhD, chief executive officer at ADASRI.
“This project will improve clinician and patient access to the evidence and recommendations for all dental specialties and will serve key stakeholder groups throughout guideline development,” said Araujo.
ADASRI and the University of Pittsburgh will collaborate to develop, disseminate, implement, and evaluate a national clinical practice guideline for the management of acute pain in dentistry.
Alonso Carrasco-Labra, DDS, MSc, PhD, senior director of ADASRI Evidence Synthesis & Translation Research, and Deborah Polk, PhD, assistant professor of dental public health in the School of Dental Medicine at the University of Pittsburgh, will serve as the project’s co-principal investigators.
“As a part of the recently founded ADA Science & Research Institute, I believe that this project reflects the strong commitment of ADASRI to conduct research on topics of great importance for the public and the dental profession,” said Carrasco-Labra.
“This award aligns with the ADA’s strong commitment toward optimal, evidence-based management of acute pain in dentistry, including the use of opioids,” said Carrasco-Labra.
This is the first grant awarded to ADASRI’s Evidence Synthesis & Translation Research team since ADASRI was launched in January 2020. It adds to the growing list of ADASRI grant awards for 2020, which also includes three National Institutes of Health grants awarded to the ADASRI Innovation & Technology Research team.